Every Form 4 that Utah Medical Products Inc (UTMD) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow UTMD and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full UTMD filings page.
UTAH MEDICAL PRODUCTS INC director Paul O. Richins reported an indirect bona fide gift of 150 shares of Common Stock. The gift was valued at $73.07 per share based on the Form 4 disclosure. After this disposition, indirect holdings total 20,765 shares.
These shares are held through various accounts and entities, including a spouse's IRA, a son's account, the reporting person's IRA, and the Richins Family Trust, as described in the footnote. The transaction reflects a non-market gift transfer rather than an open-market sale.
UTAH MEDICAL PRODUCTS INC principal financial officer Brian Koopman reported a bona fide gift transfer of 50 shares of Common Stock. The gifted shares were valued at $66.27 per share for reporting purposes. Following the gift, he directly holds 782 shares of the company’s stock.
Utah Medical Products Inc. (UTMD) reported an equity compensation award to its Principal Financial Officer. On 10/31/2025, the officer received an employee stock option to buy 500 shares of UTMD common stock at an exercise price of $58.1 per share. The option expires on 10/31/2035 and will vest 25% on 1/1/27, with an additional 6.25% vesting on 4/1/27 and on the first day of each calendar quarter thereafter, becoming fully exercisable on 1/1/30. Following this grant, the officer beneficially owned 5,600 derivative securities directly.